GlassScriptPhysician profile
Adam J Katz
NPI 1639236359
$40,034.42
in general payments reported to CMS, 2019-2025
28 companies · $8,397 in 2025
The $8,397 reported for 2025 was more than what 95% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,394 · 2020: $2,102 · 2021: $2,899 · 2022: $7,221 · 2023: $5,820 · 2024: $10K · 2025: $8,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $7,031 · Travel and Lodging: $6,737 · Education: $39.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,610.33 |
| Consulting Fee | $7,031.25 |
| Travel and Lodging | $6,736.53 |
| Education | $39.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $23,474.71 | 2019-2025 | |
| Stryker Corporation | $7,372.88 | 2019-2025 | Vitoss, Gravity, Inbone |
| Smith+Nephew, INC. | $3,353.83 | 2019-2025 | Pico, Versajet, Collagenase Santyl |
| Arthrex, INC. | $1,547.68 | 2022 | |
| Djo, LLC | $1,064.36 | 2019-2024 | Cmf |
| Paratek Pharmaceuticals, INC. | $572.36 | 2023-2025 | Nuzyra |
| Next Science LLC | $311.81 | 2023 | Xperience, Blastx, Surgx |
| Abbott Laboratories | $294.42 | 2023-2025 | Proclaim, Esprit |
| Boston Scientific Corporation | $250.48 | 2019-2025 | General - Vascular Intervention |
| Acera Surgical, INC. | $156.21 | 2022 | |
| Organogenesis INC. | $155.74 | 2021-2025 | Puraply Wound Matrix, Cygnus Dual |
| Depuy Synthes Sales INC. | $150.37 | 2022 | |
| Amgen INC. | $149.50 | 2025 | Krystexxa |
| Integra Lifesciences Corporation | $143.92 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kci USA, INC. | $123.99 | 2023 | Snap, Prevena, Activ.A.C. Ion Progress |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $123.10 | 2021 | |
| Wright Medical Technology, INC. | $118.80 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $111.32 | 2019-2022 | |
| Cerapedics INC. | $107.59 | 2022 | |
| Biotissue Holdings INC. | $102.46 | 2022 | |
| Solventum Corporation | $101.47 | 2025 | V.A.C.Ulta, V.A.C.Instill, Prevena |
| Imbed Biosciences INC. | $65.12 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $44.07 | 2022-2025 | Cabtreo, Jublia, Siliq |
| Melinta Therapeutics, LLC | $38.81 | 2019 | |
| Tei Medical INC. | $38.66 | 2019 | |
| Medshape, INC. | $26.32 | 2022 | |
| Orthofix Medical, INC. | $18.72 | 2019 | |
| Mimedx Group, INC. | $15.72 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.